CN Stock MarketDetailed Quotes

002433 Guangdong Taiantang Pharmaceutical

Watchlist
  • 0.30
  • +0.01+3.45%
Not Open Jul 3 15:00 CST
230.03MMarket Cap-104P/E (TTM)

Guangdong Taiantang Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Money funds
124.04%93.59M
188.34%122.8M
6.63%34.25M
-40.87%33.69M
-19.44%41.77M
-41.62%42.59M
-45.91%32.12M
-8.95%56.98M
-64.76%51.85M
-64.45%72.95M
Notes receivable and accounts receivable
-46.10%182.46M
-47.82%189.17M
-48.55%289.54M
-43.67%319.86M
-18.23%338.53M
-20.84%362.52M
9.79%562.76M
23.58%567.81M
-25.35%414M
-18.13%457.97M
-Notes receivable
-39.21%26.34M
-27.30%43.08M
135.32%3.87M
49.89%3.16M
380.10%43.32M
27.46%59.26M
-85.83%1.64M
-84.05%2.11M
-16.42%9.02M
155.99%46.49M
-Accounts receivable
-47.11%156.13M
-51.83%146.09M
-49.09%285.67M
-44.02%316.7M
-27.10%295.21M
-26.30%303.26M
12.01%561.11M
26.77%565.7M
-25.53%404.98M
-23.97%411.48M
Other receivables (including interest and dividends)
-46.09%253.7M
-36.02%276.33M
-2.26%599.6M
-3.35%604.9M
-24.43%470.62M
-30.70%431.86M
93.51%613.48M
83.68%625.87M
921.91%622.75M
93.02%623.14M
-Other receivable
----
----
----
-3.35%604.9M
----
--431.86M
----
83.68%625.87M
----
----
Advance payment
-91.96%20.68M
-78.91%15.2M
-44.35%192.63M
-38.08%190.62M
-16.29%257.1M
-62.36%72.06M
35.69%346.16M
36.71%307.82M
43.01%307.13M
31.00%191.44M
Inventories
-77.58%518.44M
-71.61%509.73M
-19.53%2.26B
-18.05%2.28B
-22.05%2.31B
-21.16%1.8B
1.15%2.81B
1.21%2.78B
-8.37%2.97B
-16.63%2.28B
Other current assets
14.99%75.12M
-35.41%74.43M
0.72%51.48M
23.67%61.64M
-9.20%65.33M
-0.72%115.23M
-91.71%51.11M
-91.91%49.84M
-74.95%71.95M
-67.17%116.07M
Total current assets
-67.19%1.14B
-57.88%1.19B
-22.35%3.43B
-20.49%3.49B
-21.39%3.49B
-24.59%2.82B
-2.72%4.41B
-1.41%4.39B
-1.51%4.43B
-13.43%3.74B
Non Current assets
Debt investment
----
----
----
----
--8.2K
----
----
----
----
----
Other debt investment
--8.2K
0.00%8.2K
0.00%8.2K
0.00%8.2K
----
0.00%8.2K
0.00%8.2K
0.00%8.2K
0.00%8.2K
0.00%8.2K
Other equity investment
-25.84%2.87M
-25.85%2.87M
0.00%3.87M
0.00%3.87M
-0.02%3.87M
0.00%3.87M
0.00%3.87M
0.00%3.87M
-96.01%3.87M
-96.01%3.87M
Investment real estate
76.40%180.16M
69.16%178.33M
12.82%115.23M
31.89%115.23M
16.90%102.13M
35.17%105.42M
144.04%102.13M
107.88%87.37M
107.00%87.37M
92.09%77.99M
Long-term equity investment
-2.95%296.93M
-2.44%299.68M
-2.36%303.3M
-2.21%304.53M
-2.26%305.96M
-2.22%307.19M
-50.87%310.61M
-50.71%311.42M
-2.91%313.03M
-2.81%314.17M
Fixed assets
----
----
----
-6.46%2.01B
----
-5.00%2.09B
----
-2.58%2.15B
----
-2.86%2.2B
Constru in process
----
----
----
-70.72%22.16M
----
-28.62%52.5M
----
-74.34%75.68M
----
-74.85%73.55M
Productive biological assets
0.41%3.97M
-0.24%4.21M
-0.04%4.45M
-7.65%4.64M
-3.16%3.95M
-16.53%4.22M
-21.92%4.45M
-20.88%5.02M
-25.07%4.08M
-10.31%5.06M
Intangible assets
-25.55%200.92M
-25.52%201.38M
-10.49%251.74M
-8.95%261.47M
-8.46%269.89M
-9.66%270.38M
24.32%281.25M
12.58%287.16M
1.95%294.82M
3.37%299.28M
Development expenditure
----
----
----
----
----
----
0.00%490K
0.00%490K
-97.68%490K
-97.99%490K
Goodwill
----
----
0.00%21.46M
0.00%21.46M
0.00%21.46M
0.00%30.46M
-85.85%21.46M
-85.85%21.46M
-95.40%21.46M
-93.59%30.46M
Long deferred expense
7.07%37.07M
4.67%37.21M
-28.82%24.29M
-5.62%33.42M
-7.38%34.62M
-8.52%35.55M
-10.52%34.12M
-8.92%35.41M
-9.80%37.38M
-6.00%38.86M
Deferred tax assets
-94.56%865.01K
-91.89%884.83K
-71.36%14.69M
-73.72%13.69M
-65.62%15.89M
-75.76%10.92M
55.57%51.3M
56.84%52.1M
20.46%46.23M
22.86%45.03M
Usufruct assets
2,326.46%81.37M
2,263.17%81.9M
-97.85%525.4K
-96.88%655.98K
-89.78%3.35M
-89.99%3.47M
--24.48M
--21.04M
--32.81M
1,817.81%34.64M
Other non current assets
-35.45%25.52M
-38.08%25.28M
99.26%46.04M
25.69%41.61M
50.52%39.53M
7.63%40.82M
42.10%23.11M
103.61%33.11M
-94.87%26.26M
-92.76%37.93M
Total non current assets
-25.25%2.14B
-27.07%2.16B
-14.20%2.62B
-8.11%2.83B
-7.98%2.86B
-6.54%2.96B
-16.30%3.05B
-16.23%3.08B
-28.87%3.11B
-28.41%3.16B
Total assets
-48.28%3.28B
-42.11%3.34B
-19.02%6.05B
-15.39%6.32B
-15.86%6.35B
-16.31%5.78B
-8.77%7.47B
-8.12%7.47B
-14.99%7.55B
-21.00%6.9B
Liabilities
Current liabilities
Short term loan
-5.23%780.92M
-9.22%780.92M
-16.76%759.66M
-13.39%799.16M
-12.30%824.02M
-11.49%860.21M
-11.78%912.64M
-19.90%922.74M
-29.79%939.64M
-38.53%971.92M
Notes payable and accounts payable
-4.64%479.12M
-23.57%472.45M
-26.40%454.98M
-23.06%470.5M
-18.74%502.44M
-8.98%618.18M
127.18%618.21M
171.79%611.54M
-31.11%618.35M
-18.57%679.13M
-Notes payable
----
----
----
----
----
----
----
-65.00%10.5M
-96.26%10.5M
----
-Accounts payable
-4.64%479.12M
-23.57%472.45M
-26.40%454.98M
-21.72%470.5M
-17.34%502.44M
-8.98%618.18M
155.32%618.21M
208.21%601.04M
-1.45%607.85M
-18.57%679.13M
Contract liabilities
98.26%189.51M
29.96%203.34M
41.22%149.36M
30.26%134.36M
7.50%95.59M
68.32%156.46M
7.26%105.77M
-27.74%103.15M
32.77%88.92M
81.85%92.95M
Advance receipts
38.41%17.82M
-5.52%19.15M
29.15%19.21M
26.94%18.88M
-13.45%12.87M
14.18%20.26M
--14.87M
--14.87M
--14.87M
1,594.01%17.75M
Salaries payable
48.67%17.02M
21.73%24.22M
11.70%13.21M
13.29%14.49M
-13.95%11.45M
18.97%19.9M
905.70%11.83M
352.51%12.79M
15.31%13.31M
4.87%16.73M
Taxs payable
-6.64%36.49M
-8.47%39.46M
-5.40%36.59M
0.31%39.7M
-14.27%39.08M
26.65%43.12M
-21.62%38.68M
-11.77%39.58M
185.39%45.59M
92.10%34.04M
Other payable (including interest and dividends)
182.65%369.19M
29.47%357.8M
-33.02%192.47M
-19.96%208.42M
-44.07%130.62M
1.61%276.36M
3.25%287.37M
193.70%260.38M
92.64%233.53M
26.82%271.97M
-Interest payable
----
----
----
19.66%17.19M
----
--12.73M
----
50.95%14.36M
----
----
-Other payable
----
----
----
-22.27%191.23M
----
--263.63M
----
210.86%246.01M
----
----
Non current liabilities due within one year
473.87%393.81M
517.87%396.05M
686.93%62.98M
1,402.85%63.17M
1,532.46%68.62M
1,056.85%64.1M
-95.55%8M
-98.83%4.2M
-99.57%4.2M
-99.43%5.54M
Other current liabilities
-20.83%51.16M
-29.57%44.44M
-14.62%27.44M
-1.66%28.8M
125.45%64.61M
85.15%63.09M
222.78%32.14M
234.67%29.28M
327.32%28.66M
780.42%34.08M
Total current liabilities
33.48%2.34B
10.19%2.34B
-15.45%1.72B
-11.06%1.78B
-11.97%1.75B
-0.11%2.12B
5.48%2.03B
-1.21%2B
-42.21%1.99B
-42.58%2.12B
Current liabilities
Long term loan
----
----
--937.72K
--1.56M
--4.24M
--4.39M
----
----
----
----
Long term account payable
----
----
----
-6.29%893.59M
----
-7.94%893.83M
----
404.71%953.59M
----
4,876.38%970.94M
Deferred tax liabilities
----
----
-96.81%24.74K
-65.70%391.49K
-49.73%758.25K
-40.00%1.13M
-97.92%774.74K
-96.94%1.14M
-88.07%1.51M
-85.38%1.88M
Long term deferred income
-20.04%27.81M
-22.71%28.81M
-22.81%30.66M
-22.46%32.72M
-22.15%34.78M
-20.98%37.28M
-19.97%39.72M
-19.01%42.2M
-18.49%44.67M
-17.97%47.17M
Lease liabilities
23,654.89%74.21M
23,565.90%74.81M
-99.19%134.56K
-99.86%24.36K
-98.18%312.4K
-98.90%316.11K
--16.62M
--17.58M
--17.2M
--28.7M
Total non current liabilities
-34.84%608.55M
-34.88%610.15M
-14.17%867.45M
-8.50%928.29M
-8.16%933.95M
-10.65%936.94M
158.96%1.01B
261.82%1.01B
1,114.81%1.02B
1,041.87%1.05B
Total liabilities
9.70%2.94B
-3.62%2.95B
-15.03%2.58B
-10.20%2.71B
-10.68%2.68B
-3.60%3.06B
31.36%3.04B
30.81%3.01B
-14.71%3B
-16.30%3.17B
Shareholders equity
Paid-in capital
0.00%766.77M
0.00%766.77M
0.00%766.77M
0.00%766.77M
0.00%766.77M
0.00%766.77M
0.00%766.77M
0.00%766.77M
0.00%766.77M
0.00%766.77M
Capital reserve funds
-0.03%2.93B
-1.17%2.93B
0.00%2.93B
0.00%2.93B
0.00%2.93B
-1.22%2.97B
0.53%2.93B
0.53%2.93B
0.00%2.93B
-1.23%3.01B
Surplus reserve funds
0.00%102.08M
0.00%102.08M
0.00%102.08M
0.00%102.08M
0.00%102.08M
0.00%102.08M
0.23%102.08M
0.23%102.08M
0.00%102.08M
0.00%102.08M
Retained profit
-1,246.87%-3.43B
-190.09%-3.37B
-192.21%-446.72M
-157.92%-299.14M
-142.96%-254.48M
-497.81%-1.16B
-75.60%484.44M
-73.55%516.45M
-56.88%592.43M
-120.62%-194.48M
Other composite income
0.15%5.64M
2.84%4.13M
-65.53%2.37M
-31.37%2.34M
1,646.50%5.64M
1,065.67%4.02M
621.83%6.87M
384.76%3.41M
-119.89%-364.44K
-74.85%344.68K
Shareholders equity without minority interests
-89.29%380.72M
-83.80%434.02M
-21.79%3.36B
-18.89%3.51B
-19.13%3.55B
-27.21%2.68B
-25.63%4.29B
-24.70%4.32B
-15.13%4.4B
-24.22%3.68B
Minority interests
-136.01%-40.19M
-197.72%-38.3M
-20.84%104.56M
-18.95%109.39M
-24.00%111.6M
-21.24%39.19M
37.98%132.09M
55.46%134.96M
-16.65%146.83M
-45.22%49.76M
Total shareholder equity
-90.71%340.53M
-85.44%395.72M
-21.76%3.46B
-18.89%3.62B
-19.29%3.67B
-27.13%2.72B
-24.59%4.43B
-23.50%4.46B
-15.18%4.54B
-24.60%3.73B
Total liabilityies and equity
-48.28%3.28B
-42.11%3.34B
-19.02%6.05B
-15.39%6.32B
-15.86%6.35B
-16.31%5.78B
-8.77%7.47B
-8.12%7.47B
-14.99%7.55B
-21.00%6.9B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Disclaimer of Opinion
--
--
--
Disclaimer of Opinion
--
--
--
Reservations with explanatory notes
Auditor
--
Sichuan Huaxin (Group) Accounting Firm (Special General Partnership)
--
--
--
ZTE Certified Public Accountants (Special General Partnership)
--
--
--
ZTE Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Money funds 124.04%93.59M188.34%122.8M6.63%34.25M-40.87%33.69M-19.44%41.77M-41.62%42.59M-45.91%32.12M-8.95%56.98M-64.76%51.85M-64.45%72.95M
Notes receivable and accounts receivable -46.10%182.46M-47.82%189.17M-48.55%289.54M-43.67%319.86M-18.23%338.53M-20.84%362.52M9.79%562.76M23.58%567.81M-25.35%414M-18.13%457.97M
-Notes receivable -39.21%26.34M-27.30%43.08M135.32%3.87M49.89%3.16M380.10%43.32M27.46%59.26M-85.83%1.64M-84.05%2.11M-16.42%9.02M155.99%46.49M
-Accounts receivable -47.11%156.13M-51.83%146.09M-49.09%285.67M-44.02%316.7M-27.10%295.21M-26.30%303.26M12.01%561.11M26.77%565.7M-25.53%404.98M-23.97%411.48M
Other receivables (including interest and dividends) -46.09%253.7M-36.02%276.33M-2.26%599.6M-3.35%604.9M-24.43%470.62M-30.70%431.86M93.51%613.48M83.68%625.87M921.91%622.75M93.02%623.14M
-Other receivable -------------3.35%604.9M------431.86M----83.68%625.87M--------
Advance payment -91.96%20.68M-78.91%15.2M-44.35%192.63M-38.08%190.62M-16.29%257.1M-62.36%72.06M35.69%346.16M36.71%307.82M43.01%307.13M31.00%191.44M
Inventories -77.58%518.44M-71.61%509.73M-19.53%2.26B-18.05%2.28B-22.05%2.31B-21.16%1.8B1.15%2.81B1.21%2.78B-8.37%2.97B-16.63%2.28B
Other current assets 14.99%75.12M-35.41%74.43M0.72%51.48M23.67%61.64M-9.20%65.33M-0.72%115.23M-91.71%51.11M-91.91%49.84M-74.95%71.95M-67.17%116.07M
Total current assets -67.19%1.14B-57.88%1.19B-22.35%3.43B-20.49%3.49B-21.39%3.49B-24.59%2.82B-2.72%4.41B-1.41%4.39B-1.51%4.43B-13.43%3.74B
Non Current assets
Debt investment ------------------8.2K--------------------
Other debt investment --8.2K0.00%8.2K0.00%8.2K0.00%8.2K----0.00%8.2K0.00%8.2K0.00%8.2K0.00%8.2K0.00%8.2K
Other equity investment -25.84%2.87M-25.85%2.87M0.00%3.87M0.00%3.87M-0.02%3.87M0.00%3.87M0.00%3.87M0.00%3.87M-96.01%3.87M-96.01%3.87M
Investment real estate 76.40%180.16M69.16%178.33M12.82%115.23M31.89%115.23M16.90%102.13M35.17%105.42M144.04%102.13M107.88%87.37M107.00%87.37M92.09%77.99M
Long-term equity investment -2.95%296.93M-2.44%299.68M-2.36%303.3M-2.21%304.53M-2.26%305.96M-2.22%307.19M-50.87%310.61M-50.71%311.42M-2.91%313.03M-2.81%314.17M
Fixed assets -------------6.46%2.01B-----5.00%2.09B-----2.58%2.15B-----2.86%2.2B
Constru in process -------------70.72%22.16M-----28.62%52.5M-----74.34%75.68M-----74.85%73.55M
Productive biological assets 0.41%3.97M-0.24%4.21M-0.04%4.45M-7.65%4.64M-3.16%3.95M-16.53%4.22M-21.92%4.45M-20.88%5.02M-25.07%4.08M-10.31%5.06M
Intangible assets -25.55%200.92M-25.52%201.38M-10.49%251.74M-8.95%261.47M-8.46%269.89M-9.66%270.38M24.32%281.25M12.58%287.16M1.95%294.82M3.37%299.28M
Development expenditure ------------------------0.00%490K0.00%490K-97.68%490K-97.99%490K
Goodwill --------0.00%21.46M0.00%21.46M0.00%21.46M0.00%30.46M-85.85%21.46M-85.85%21.46M-95.40%21.46M-93.59%30.46M
Long deferred expense 7.07%37.07M4.67%37.21M-28.82%24.29M-5.62%33.42M-7.38%34.62M-8.52%35.55M-10.52%34.12M-8.92%35.41M-9.80%37.38M-6.00%38.86M
Deferred tax assets -94.56%865.01K-91.89%884.83K-71.36%14.69M-73.72%13.69M-65.62%15.89M-75.76%10.92M55.57%51.3M56.84%52.1M20.46%46.23M22.86%45.03M
Usufruct assets 2,326.46%81.37M2,263.17%81.9M-97.85%525.4K-96.88%655.98K-89.78%3.35M-89.99%3.47M--24.48M--21.04M--32.81M1,817.81%34.64M
Other non current assets -35.45%25.52M-38.08%25.28M99.26%46.04M25.69%41.61M50.52%39.53M7.63%40.82M42.10%23.11M103.61%33.11M-94.87%26.26M-92.76%37.93M
Total non current assets -25.25%2.14B-27.07%2.16B-14.20%2.62B-8.11%2.83B-7.98%2.86B-6.54%2.96B-16.30%3.05B-16.23%3.08B-28.87%3.11B-28.41%3.16B
Total assets -48.28%3.28B-42.11%3.34B-19.02%6.05B-15.39%6.32B-15.86%6.35B-16.31%5.78B-8.77%7.47B-8.12%7.47B-14.99%7.55B-21.00%6.9B
Liabilities
Current liabilities
Short term loan -5.23%780.92M-9.22%780.92M-16.76%759.66M-13.39%799.16M-12.30%824.02M-11.49%860.21M-11.78%912.64M-19.90%922.74M-29.79%939.64M-38.53%971.92M
Notes payable and accounts payable -4.64%479.12M-23.57%472.45M-26.40%454.98M-23.06%470.5M-18.74%502.44M-8.98%618.18M127.18%618.21M171.79%611.54M-31.11%618.35M-18.57%679.13M
-Notes payable -----------------------------65.00%10.5M-96.26%10.5M----
-Accounts payable -4.64%479.12M-23.57%472.45M-26.40%454.98M-21.72%470.5M-17.34%502.44M-8.98%618.18M155.32%618.21M208.21%601.04M-1.45%607.85M-18.57%679.13M
Contract liabilities 98.26%189.51M29.96%203.34M41.22%149.36M30.26%134.36M7.50%95.59M68.32%156.46M7.26%105.77M-27.74%103.15M32.77%88.92M81.85%92.95M
Advance receipts 38.41%17.82M-5.52%19.15M29.15%19.21M26.94%18.88M-13.45%12.87M14.18%20.26M--14.87M--14.87M--14.87M1,594.01%17.75M
Salaries payable 48.67%17.02M21.73%24.22M11.70%13.21M13.29%14.49M-13.95%11.45M18.97%19.9M905.70%11.83M352.51%12.79M15.31%13.31M4.87%16.73M
Taxs payable -6.64%36.49M-8.47%39.46M-5.40%36.59M0.31%39.7M-14.27%39.08M26.65%43.12M-21.62%38.68M-11.77%39.58M185.39%45.59M92.10%34.04M
Other payable (including interest and dividends) 182.65%369.19M29.47%357.8M-33.02%192.47M-19.96%208.42M-44.07%130.62M1.61%276.36M3.25%287.37M193.70%260.38M92.64%233.53M26.82%271.97M
-Interest payable ------------19.66%17.19M------12.73M----50.95%14.36M--------
-Other payable -------------22.27%191.23M------263.63M----210.86%246.01M--------
Non current liabilities due within one year 473.87%393.81M517.87%396.05M686.93%62.98M1,402.85%63.17M1,532.46%68.62M1,056.85%64.1M-95.55%8M-98.83%4.2M-99.57%4.2M-99.43%5.54M
Other current liabilities -20.83%51.16M-29.57%44.44M-14.62%27.44M-1.66%28.8M125.45%64.61M85.15%63.09M222.78%32.14M234.67%29.28M327.32%28.66M780.42%34.08M
Total current liabilities 33.48%2.34B10.19%2.34B-15.45%1.72B-11.06%1.78B-11.97%1.75B-0.11%2.12B5.48%2.03B-1.21%2B-42.21%1.99B-42.58%2.12B
Current liabilities
Long term loan ----------937.72K--1.56M--4.24M--4.39M----------------
Long term account payable -------------6.29%893.59M-----7.94%893.83M----404.71%953.59M----4,876.38%970.94M
Deferred tax liabilities ---------96.81%24.74K-65.70%391.49K-49.73%758.25K-40.00%1.13M-97.92%774.74K-96.94%1.14M-88.07%1.51M-85.38%1.88M
Long term deferred income -20.04%27.81M-22.71%28.81M-22.81%30.66M-22.46%32.72M-22.15%34.78M-20.98%37.28M-19.97%39.72M-19.01%42.2M-18.49%44.67M-17.97%47.17M
Lease liabilities 23,654.89%74.21M23,565.90%74.81M-99.19%134.56K-99.86%24.36K-98.18%312.4K-98.90%316.11K--16.62M--17.58M--17.2M--28.7M
Total non current liabilities -34.84%608.55M-34.88%610.15M-14.17%867.45M-8.50%928.29M-8.16%933.95M-10.65%936.94M158.96%1.01B261.82%1.01B1,114.81%1.02B1,041.87%1.05B
Total liabilities 9.70%2.94B-3.62%2.95B-15.03%2.58B-10.20%2.71B-10.68%2.68B-3.60%3.06B31.36%3.04B30.81%3.01B-14.71%3B-16.30%3.17B
Shareholders equity
Paid-in capital 0.00%766.77M0.00%766.77M0.00%766.77M0.00%766.77M0.00%766.77M0.00%766.77M0.00%766.77M0.00%766.77M0.00%766.77M0.00%766.77M
Capital reserve funds -0.03%2.93B-1.17%2.93B0.00%2.93B0.00%2.93B0.00%2.93B-1.22%2.97B0.53%2.93B0.53%2.93B0.00%2.93B-1.23%3.01B
Surplus reserve funds 0.00%102.08M0.00%102.08M0.00%102.08M0.00%102.08M0.00%102.08M0.00%102.08M0.23%102.08M0.23%102.08M0.00%102.08M0.00%102.08M
Retained profit -1,246.87%-3.43B-190.09%-3.37B-192.21%-446.72M-157.92%-299.14M-142.96%-254.48M-497.81%-1.16B-75.60%484.44M-73.55%516.45M-56.88%592.43M-120.62%-194.48M
Other composite income 0.15%5.64M2.84%4.13M-65.53%2.37M-31.37%2.34M1,646.50%5.64M1,065.67%4.02M621.83%6.87M384.76%3.41M-119.89%-364.44K-74.85%344.68K
Shareholders equity without minority interests -89.29%380.72M-83.80%434.02M-21.79%3.36B-18.89%3.51B-19.13%3.55B-27.21%2.68B-25.63%4.29B-24.70%4.32B-15.13%4.4B-24.22%3.68B
Minority interests -136.01%-40.19M-197.72%-38.3M-20.84%104.56M-18.95%109.39M-24.00%111.6M-21.24%39.19M37.98%132.09M55.46%134.96M-16.65%146.83M-45.22%49.76M
Total shareholder equity -90.71%340.53M-85.44%395.72M-21.76%3.46B-18.89%3.62B-19.29%3.67B-27.13%2.72B-24.59%4.43B-23.50%4.46B-15.18%4.54B-24.60%3.73B
Total liabilityies and equity -48.28%3.28B-42.11%3.34B-19.02%6.05B-15.39%6.32B-15.86%6.35B-16.31%5.78B-8.77%7.47B-8.12%7.47B-14.99%7.55B-21.00%6.9B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Disclaimer of Opinion------Disclaimer of Opinion------Reservations with explanatory notes
Auditor --Sichuan Huaxin (Group) Accounting Firm (Special General Partnership)------ZTE Certified Public Accountants (Special General Partnership)------ZTE Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg